Literature DB >> 11326483

Risk factors for infection and role of C-reactive protein in Korean patients with systemic lupus erythematosus.

C H Suh1, Y S Jeong, H C Park, C H Lee, J Lee, C H Song, W K Lee, Y B Park, J Song, S K Lee.   

Abstract

To evaluate risk factors for infection and the role of C-reactive protein (CRP) in the diagnosis of infection, a retrospective case control study was performed among Korean systemic lupus erythematosus patients. Of 120 proven infections, 31 episodes (25.8%) occurred in patients taking no corticosteroids (CS). The risk of infection was lower in patients taking low-dose CS (< 300 mg prednisolone/month) than no CS (odds ratio (OR) 0.36). In patients receiving high-dose CS (> 1000 mg prednisolone/month), however, the risk increased (OR 2.9). In patients taking no CS, disease activity manifested as increased SLEDAI, anemia and active urinary sediment, was associated with infection. The CRP was higher in the patients with infection than controls and the CRP levels over 50 mg/l were observed only in infection. These results suggest that CS have a bimodal influence on infection depending on dose. Disease activity is an important risk factor for infection in patients taking no CS. Finally, CRP levels greater than 50 mg/l suggest the presence of infection.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11326483

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  12 in total

1.  Does erythrocyte sedimentation rate reflect and discriminate flare from infection in systemic lupus erythematosus? Correlation with clinical and laboratory parameters of disease activity.

Authors:  Valentin Sebastian Schäfer; Katharina Weiß; Andreas Krause; Wolfgang Andreas Schmidt
Journal:  Clin Rheumatol       Date:  2018-04-14       Impact factor: 2.980

2.  Usefulness of neutrophil-to-lymphocyte ratio as a biomarker for diagnosing infections in patients with systemic lupus erythematosus.

Authors:  Hyoun-Ah Kim; Ju-Yang Jung; Chang-Hee Suh
Journal:  Clin Rheumatol       Date:  2017-08-24       Impact factor: 2.980

3.  Significantly higher percentage of circulating CD27(high) plasma cells in systemic lupus erythematosus patients with infection than with disease flare-up.

Authors:  Deng-Ho Yang; Deh-Ming Chang; Jenn-Haung Lai; Fu-Huang Lin; Chen-Hung Chen
Journal:  Yonsei Med J       Date:  2010-11       Impact factor: 2.759

4.  Cytokine IL-6 and IL-10 as biomarkers in systemic lupus erythematosus.

Authors:  Hye-Young Chun; Jae-Wook Chung; Hyoun-Ah Kim; Jeong-Moon Yun; Ja-Young Jeon; Young-Min Ye; Seung-Hyun Kim; Hae-Sim Park; Chang-Hee Suh
Journal:  J Clin Immunol       Date:  2007-06-21       Impact factor: 8.317

5.  High-sensitivity C-reactive protein, disease activity, and cardiovascular risk factors in systemic lupus erythematosus.

Authors:  Chi Chiu Mok; Daniel J Birmingham; Ling Yin Ho; Lee A Hebert; Brad H Rovin
Journal:  Arthritis Care Res (Hoboken)       Date:  2013-03       Impact factor: 4.794

Review 6.  SLE and infections.

Authors:  Gisele Zandman-Goddard; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2003-08       Impact factor: 8.667

7.  Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): LXI. Value of C-reactive protein as a marker of disease activity and damage.

Authors:  Ana M Bertoli; Luis M Vilá; John D Reveille; Graciela S Alarcón
Journal:  J Rheumatol       Date:  2008-11-01       Impact factor: 4.666

Review 8.  Infection in systemic lupus erythematosus, similarities, and differences with lupus flare.

Authors:  Ju-Yang Jung; Chang-Hee Suh
Journal:  Korean J Intern Med       Date:  2017-04-28       Impact factor: 2.884

9.  The relationship between anti-C-reactive protein and disease activity in patients with systemic lupus erythematosus.

Authors:  Chang-Nam Son; Tae-Han Lee; Ji-Hye Bang; Hye-Jin Jeong; Jin-Nyeong Chae; Won-Mok Lee; Ji-Min Kim; Sang-Hyon Kim
Journal:  Korean J Intern Med       Date:  2017-03-31       Impact factor: 2.884

10.  Thromboangiitis obliterans episode: autoimmune flare-up or reinfection?

Authors:  Mehran Mohareri; Ali Mirhosseini; Saeedeh Mehraban; Bahare Fazeli
Journal:  Vasc Health Risk Manag       Date:  2018-09-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.